Mossler Mark

Mossler Mark is listed in filings as Chief Accounting Officer at C4 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 18, 2026, including 4 public disclosures. Recent filings connect the profile to C4 Therapeutics, Inc. (CCCC). The current snapshot covers public activity from Feb 18, 2025 to Feb 18, 2026. Reported amounts are shown as $6.2K to $5.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.